$35.60
0.732.09%
At Close: -
$35.60
00.00%
After Hours: 4:46 PM EDT
15 minutes delayed
Comments
Loading...
Corcept Therapeutics (NASDAQ:CORT) Stock, Earnings Estimates, EPS, And Revenue
Corcept Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 29
EPS Estimate
$0.230
Quarterly Revenue Estimate
$155.2M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$523.5M
Analyze the earnings history of Corcept Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | Corcept Therapeutics | $0.25 | $0.23 | — | — | $117.72M | $155.23M | — | — | 07/29/2024 | Get Alert |
| CORT | Corcept Therapeutics | $0.14 | $0.22 | $0.25 | 13.64% | $105.65M | $140.80M | $146.81M | 4.27% | 05/01/2024 | Get Alert |
| CORT | Corcept Therapeutics | $0.14 | $0.26 | $0.28 | 7.69% | $103.06M | $129.30M | $135.41M | 4.72% | 02/15/2024 | Get Alert |
| CORT | Corcept Therapeutics | $0.30 | $0.21 | $0.28 | 33.33% | $101.73M | $119.34M | $123.60M | 3.57% | 11/01/2023 | Get Alert |
| CORT | Corcept Therapeutics | $0.24 | $0.15 | $0.25 | 66.67% | $103.39M | $109.71M | $117.72M | 7.30% | 08/02/2023 | Get Alert |
| CORT | Corcept Therapeutics | $0.20 | $0.19 | $0.14 | -26.32% | $93.70M | $104.87M | $105.65M | 0.75% | 05/03/2023 | Get Alert |
| CORT | Corcept Therapeutics | $0.35 | $0.22 | $0.14 | -36.36% | $98.82M | $105.08M | $103.06M | -1.93% | 02/28/2023 | Get Alert |
| CORT | Corcept Therapeutics | $0.30 | $0.22 | $0.30 | 36.36% | $96.13M | $107.59M | $101.73M | -5.45% | 11/03/2022 | Get Alert |
| CORT | Corcept Therapeutics | $0.30 | $0.21 | $0.24 | 14.29% | $91.59M | $101.00M | $103.39M | 2.36% | 08/03/2022 | Get Alert |
| CORT | Corcept Therapeutics | $0.20 | $0.24 | $0.20 | -16.67% | $79.44M | $98.88M | $93.70M | -5.24% | 05/05/2022 | Get Alert |
| CORT | Corcept Therapeutics | $0.27 | $0.21 | $0.35 | 66.67% | $85.73M | $100.57M | $98.82M | -1.74% | 02/15/2022 | Get Alert |
| CORT | Corcept Therapeutics | $0.24 | $0.20 | $0.30 | 50.00% | $86.33M | $97.19M | $96.13M | -1.09% | 11/03/2021 | Get Alert |
| CORT | Corcept Therapeutics | $0.32 | $0.16 | $0.30 | 87.50% | $88.56M | $86.84M | $91.59M | 5.47% | 07/29/2021 | Get Alert |
| CORT | Corcept Therapeutics | $0.34 | $0.21 | $0.20 | -4.76% | $93.25M | $91.81M | $79.44M | -13.48% | 05/06/2021 | Get Alert |
| CORT | Corcept Therapeutics | $0.33 | $0.19 | $0.27 | 42.11% | $87.89M | $87.77M | $85.73M | -2.32% | 02/23/2021 | Get Alert |
| CORT | Corcept Therapeutics | $0.31 | $0.20 | $0.24 | 20.00% | $81.50M | $90.87M | $86.33M | -5.00% | 11/03/2020 | Get Alert |
| CORT | Corcept Therapeutics | $0.25 | $0.22 | $0.32 | 45.45% | $72.26M | $90.14M | $88.56M | -1.75% | 08/04/2020 | Get Alert |
| CORT | Corcept Therapeutics | $0.20 | $0.22 | $0.34 | 54.55% | $64.83M | $87.01M | $93.25M | 7.17% | 05/04/2020 | Get Alert |
| CORT | Corcept Therapeutics | $0.24 | $0.25 | $0.33 | 32.00% | $66.83M | $87.67M | $87.89M | 0.26% | 02/20/2020 | Get Alert |
| CORT | Corcept Therapeutics | $0.22 | $0.20 | $0.31 | 55.00% | $64.44M | $78.00M | $81.50M | 4.49% | 11/07/2019 | Get Alert |
| CORT | Corcept Therapeutics | $0.20 | $0.18 | $0.25 | 38.89% | $62.31M | $70.88M | $72.26M | 1.94% | 08/01/2019 | Get Alert |
Corcept Therapeutics (CORT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-01 | $0.25 | $0.22 | 13.6 % |
| Dec 2023 | 2024-02-15 | $0.28 | $0.26 | 7.69 % |
| Sep 2023 | 2023-11-01 | $0.28 | $0.21 | 33.3 % |
| Jun 2023 | 2023-08-02 | $0.25 | $0.15 | 66.7 % |
Corcept Therapeutics (CORT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-01 | $146.81M | $140.80M | 4.27 % |
| Dec 2023 | 2024-02-15 | $135.41M | $129.30M | 4.72 % |
| Sep 2023 | 2023-11-01 | $123.60M | $119.34M | 3.57 % |
| Jun 2023 | 2023-08-02 | $117.72M | $109.71M | 7.30 % |
FAQ
When is Corcept Therapeutics (NASDAQ:CORT) reporting earnings?
Corcept Therapeutics (CORT) is scheduled to report earnings on July 29, 2024. The last reported earnings were for reported on May 1, 2024 for Q1.
What were the latest earnings per share (EPS) for Corcept Therapeutics (NASDAQ:CORT)?
The Actual EPS was $0.25, which beat the estimate of $0.22.
What were Corcept Therapeutics’s (NASDAQ:CORT) revenues?
The Actual Revenue was $146.8M, which beat the estimate of $140.8M.
Browse earnings estimates, EPS, and revenue on all stocks.